EV Biologics (EV Biologics) Market Cap : $6.36 Mil (As of Apr. 30, 2024)

View and export this data going back to 2015. Start your Free Trial

What is EV Biologics Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). EV Biologics's share price for the quarter that ended in Dec. 2017 was $2.7. EV Biologics's Shares Outstanding (EOP) for the quarter that ended in Dec. 2017 was 2.41 Mil. Therefore, EV Biologics's market cap for the quarter that ended in Dec. 2017 was $6.51 Mil.

EV Biologics's quarterly market cap declined from Dec. 2016 ($10.56 Mil) to Jun. 2017 ($6.12 Mil) but then increased from Jun. 2017 ($6.12 Mil) to Dec. 2017 ($6.51 Mil).

EV Biologics's annual market cap declined from Jun. 2015 ($48.00 Mil) to Jun. 2016 ($20.56 Mil) and declined from Jun. 2016 ($20.56 Mil) to Jun. 2017 ($6.12 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. EV Biologics's Enterprise Value for Today is $6.36 Mil.

EV Biologics Market Cap Historical Data

The historical data trend for EV Biologics's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EV Biologics Market Cap Chart

EV Biologics Annual Data

Trend

Jun13

Jun14

Jun15

Jun16

Jun17

Market Cap

48.00

20.56

6.12

EV Biologics Quarterly Data
	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Jun17	Dec17
Market Cap	Get a 7-Day Free Trial												20.56	28.09	10.56	6.12	6.51

Competitive Comparison of EV Biologics's Market Cap

For the Biotechnology subindustry, EV Biologics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

EV Biologics's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, EV Biologics's Market Cap distribution charts can be found below:

* The bar in red indicates where EV Biologics's Market Cap falls into.

EV Biologics Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

EV Biologics's Market Cap for the fiscal year that ended in Jun. 2017 is calculated as

Market Cap (A: Jun. 2017 )	=	Share Price (A: Jun. 2017 )	*	Shares Outstanding (EOP) (A: Jun. 2017 )
	=	$2.54	*	2.41107
	=	$6.12

EV Biologics's Market Cap for the quarter that ended in Dec. 2017 is calculated as

Market Cap (Q: Dec. 2017 )	=	Share Price (Q: Dec. 2017 )	*	Shares Outstanding (EOP) (Q: Dec. 2017 )
	=	$2.7	*	2.41107
	=	$6.51

EV Biologics (OTCPK:YECO) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

EV Biologics Market Cap Related Terms

Thank you for viewing the detailed overview of EV Biologics's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

EV Biologics (EV Biologics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EV Biologics Inc (OTCPK:YECO) » Definitions » Market Cap

Comparable Companies

XCNQ:NIRV ENVB BLCM NLSP BRTX ADTX XKRX:066830 ALLR XMAD:ADL ARTL

Traded in Other Exchanges

N/A

Address

1621 Central Avenue, Cheyenne, WY, USA, 82001

Website

https://www.evbiologics.com

EV Biologics Inc is developing the extraordinary biological properties of extracellular vesicles (EVs) to create the next generation of diagnostic modalities and safe, effective biotherapeutics to improve outcomes of serious clinical conditions, increase natural longevity and transform lives.

Executives

Daniel S Mckinney	director, 10 percent owner, officer: CEO	TWO IFC, 19TH FLOOR, 8 FINANCE STREET, CENTRAL, HONG KONG F4 000000
Michael W Harlan	director	C/O WASTE CONNECTIONS, INC., 610 APPLEWOOD CRESCENT, SUITE 200, VAUGHAN A6 L4K 0C3